author-photo

Stefan Schneider

St. Mary Medical Center

2

Papers

12

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.

2015 Hiv Clinical Trials
Show All
- Source
- Cite
- Save
Citations (4)
Short-term Safety and Tolerability of a Once-Daily Fixed-Dose Abacavir-Lamivudine Combination versus Twice-Daily Dosing of Abacavir and Lamivudine as Separate Components: Findings from the ALOHA Study

2008 Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (8)